Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial
Inserm · Assistance Publique – Hôpitaux de Paris · +4 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,057
total citations
- FWCI
- 84.61
- Percentile
- 100%
- References
- 33
Citations per year
Authors
7- GMGilles MontalescotCorresponding
Inserm, Assistance Publique – Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Sorbonne Université
- SDStephen D. Wiviott
Brigham and Women's Hospital, Thrombolysis in Myocardial Infarction Study Group
- EBEugene Braunwald
Thrombolysis in Myocardial Infarction Study Group, Brigham and Women's Hospital
- SASabina A. Murphy
Thrombolysis in Myocardial Infarction Study Group, Brigham and Women's Hospital
- CMC. Michael Gibson
Thrombolysis in Myocardial Infarction Study Group, Brigham and Women's Hospital
Topics & keywords
Topics
Keywords
- Clopidogrel
- Medicine
- Prasugrel
- Percutaneous coronary intervention
- TIMI
- Cardiology
- Internal medicine
- Myocardial infarction
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.